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ImatinibIn mammals, primordial follicles are generated early in life and remain dormant for prolonged intervals. Their
growth resumes via a process known as primordial follicle activation. Recent genetic studies have
demonstrated that phosphoinositide 3-kinase (PI3K) is the essential signaling pathway controlling this
process throughout life, acting via Akt to regulate nucleocytoplasmic shuttling of Foxo3, which functions as a
downstream molecular switch. The receptor tyrosine kinase Kit has been implicated by numerous studies as
the critical upstream regulator of primordial follicle activation via PI3K/Akt. Here we present a genetic
analysis of the contribution of Kit in regulating primordial follicle activation and early follicle growth,
employing a knock-in mutation (KitY719F) that completely abrogates signaling via PI3K. Surprisingly,
homozygous KitY719F female mice undergo primordial follicle activation and are fertile, demonstrating that
Kit signaling via PI3K is dispensable for this process. However, other abnormalities were identiﬁed in KitY719F
ovaries, including accelerated primordial follicle depletion and accumulation of morphologically abnormal
primary/secondary follicles with persistent nuclear Foxo3 localization. These ﬁndings reveal speciﬁc roles of
Kit in the maintenance of the primordial follicle reserve and in the primary to secondary follicle transition,
but argue that Kit is dispensable in primordial follicle activation.© 2009 Elsevier Inc. All rights reserved.IntroductionPrimordial follicle activation (PFA) is the metered process by
which primordial follicles are selected from the reserve pool into the
growing follicle pool (McLaughlin and McIver, 2009). PFA and the
ensuing follicle growth are irreversible; follicles that have initiated
growth undergo atresia if not selected for subsequent stages of
maturation (Peters et al., 1975). Morphologically, PFA is characterized
by oocyte growth and transition of ﬂat to cuboidal granulosa cells,
accompanied by granulosa cell proliferation (Lintern-Moore and
Moore, 1979). Primordial follicle numbers decrease as a function of
aging, and their depletion culminates in the cessation of ovulation and
reproductive senescence (menopause). Thus, the study of pathways
regulating primordial follicle maintenance is necessary to shed light
on the biological basis of menopause and several forms of female
infertility characterized by accelerated primordial follicle depletion,
such as primary ovarian insufﬁciency (Gosden et al., 1983; Nelson,
2009; Richardson et al., 1987).
PFA, unlike later stages of follicle maturation, is regulated largely
within the ovary itself, and is independent of pituitary gonadotropins
(Eppig and O'Brien, 1996; Mason et al., 1986; Matzuk et al., 2002;6000 Harry Hines Boulevard,
(D.H. Castrillon).
l rights reserved.Peters et al., 1973). This and other ﬁndings have suggested that the
oocyte communicates with and receives inputs from surrounding
somatic cells (granulosa cells) and that these signals are integrated
within the oocyte—i.e., the growth trigger mechanism functions
within the oocyte itself. This general model was supported by the
discovery of the forkhead transcription factor Foxo3 as a key regulator
that functions within oocytes to regulate PFA (John et al., 2008).
Foxo3-deﬁcient mice complete primordial follicle development
normally (John et al., 2007) but then undergo spontaneous global
activation of all their primordial follicles immediately after their
assembly is complete, leading to premature loss of all follicles and
ensuing ovarian failure (Castrillon et al., 2003; Hosaka et al., 2004).
Consistent with their participation in diverse metabolic processes,
the Foxo transcription factors are regulated by numerous post-
translational modiﬁcations including phosphorylation, acetylation,
and ubiquitination through a number of distinct biochemical path-
ways (van der Horst and Burgering, 2007). Thus, it was not initially
clear which signaling pathway(s) might be relevant in the control of
PFA via Foxo3. However, recent studies have provided strong evidence
that the PI3K pathway is the critical signaling pathway regulating PFA
via Foxo3. Foxo3 becomes phosphorylated at an Akt consensus
phosphorylation sequence and this phosphorylation appears to
mediate nuclear vs. cytoplasmic localization (John et al., 2008). Akt
is regulated by PI3K, implicating the PI3K pathway as the critical
signaling pathway regulating PFA via Foxo3. Genetic evidence
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oocyte-speciﬁc knockout of Pten (a potent inhibitor of PI3K signaling),
which resulted in a global PFA phenotype closely resembling that
observed in Foxo3 mice (John et al., 2008; Reddy et al., 2008).
Importantly, Pten inactivation within the oocyte resulted in Akt and
Foxo3 hyperphosphorylation, resulting in the nuclear export and
inactivation of Foxo3. Thus, the PI3K pathway controls PFA by
regulating Foxo3 phosphorylation and hence its subcellular localiza-
tion (John et al., 2008).
In most physiologic contexts, PI3K activity is regulated by
transmembrane receptor tyrosine kinases (RTK), raising the question
of the identity of the relevant upstream receptor (and ligand) in the
context of PFA. It seems likely that an RTK expressed on the oocyte
surface, or perhaps multiple cooperating RTKs, would serve to
integrate currently unidentiﬁed external signals produced by granu-
losa cells or other ovarian cellular compartments to regulate PFA
through the PI3K/Akt/Foxo3 pathway.
Although several RTKs have been proposed to serve this function
(reviewed in McLaughlin and McIver, 2009) a wide range of
observations have made the Kit receptor a particularly attractive
and favored candidate in this regard (Thomas and Vanderhyden,
2006). Kit and Kit ligand (Kitl) have well-documented functions in
the germ cell lineage, being required for multiple stages of
primordial germ cell survival, proliferation, migration, and differ-
entiation (Bedell and Mahakali Zama, 2004). Kit signals through
multiple pathways, including PI3K (Linnekin, 1999), which is
especially important for Kit functions within the germline (De
Miguel et al., 2002; Kissel et al., 2000; Serve et al., 1994). Kit is
expressed on the primordial oocyte membrane, while KL is
produced by granulosa cells, further making functional roles of
this receptor/ligand pair in PFA plausible. In addition, certain alleles
of the murine Kitl (a.k.a. Steel (Sl)) locus result in severe ovarian
defects. Female mice homozygous for the hypomorphic Kitl allele
Steelpanda (KitlSl-pan), which results in decreased ovarian expression
of Kitl due to a translocation breakpoint involving the Kitl upstream
regulatory region, form ovaries with follicles that become arrested
at an early stage of maturation (Bedell et al., 1995; Besmer et al.,
1993; Huang et al., 1993). Other combinations of Kitl alleles have
similar phenotypic consequences (Kuroda et al., 1988). Although
these phenotypes have in the past been interpreted as evidence for
a role of Kitl in PFA, the severe and pleiotropic ovarian phenotypes
associated with these alleles has obscured their interpretation
(Bedell et al., 1995; Huang et al., 1993).
In addition to these genetic studies, antibody-mediated blockade
of Kit reportedly disrupts primordial follicle growth in vivo (Yoshida et
al., 1997) and in vitro (Packer et al., 1994), and recombinant Kitl
induces PFA in cultured ovaries (Parrott and Skinner, 1999; Thomas et
al., 2008). On the other hand, the observed effects have been small in
magnitude or carried out with in vitro systems that can be maintained
for only short intervals and thus provide only an extremely limited
timescale for the study of PFA. In addition, some of these studies have
not distinguished between oocyte growth in general and PFA per se.
Kit activates PI3K through a direct interaction with an SH2 domain
on the p85 regulatory subunit of PI3K. This interaction is entirely
dependent on Kit tyrosine residue 719, which undergoes autopho-
sphorylation following ligand binding. Mutation of this tyrosine
residue prevents binding of Kit to p85 and thus completely abrogates
Kit signaling via PI3K (Serve et al., 1994). “Knock-in” mice harboring
this mutation (KitY719F) have been engineered by homologous
recombination, permitting a formal genetic dissection of the con-
tribution of PI3K signaling to diverse Kit-dependent biological
processes (Blume-Jensen et al., 2000; Kissel et al., 2000). Homozygous
KitY719F males are sterile with severe defects in spermatogenesis,
demonstrating an important role of PI3K-dependent Kit signaling in
the context of germ cell function. However, the impact of this
mutation on PFA has not been formally evaluated. In light of the recentdemonstration that PI3K is the prime regulator of Foxo3 and PFA we
were prompted to perform detailed analyses of KitY719F ovaries in vivo.
These analyses were complemented by studies of the impact of
pharmacologic inhibition of Kit through the use of imatinib in vitro.
The results also prompted us to re-evaluate the ovarian phenotype
associated with the KitlSl-pan mutation. Surprisingly, our ﬁndings
suggest that Kit plays a relatively minor and dispensable role in PFA,
arguing that other receptors contribute to this process. However, we
uncovered other essential roles of Kit-dependent PI3K signaling in the
ovary, namely, in the maintenance of primordial follicles and in the
transition of primary to secondary follicles. The latter phenotype was
associated with abnormal stabilization of the Foxo3 protein in the
oocyte nucleus.
Materials and methods
Mouse strains, breeding, and analysis
This study was approved by an Institutional Animal Care and Use
Committee. Generation and characterization of the KitlSl-pan and KitY719F
alleles were described previously (Bedell et al.,1995; Huang et al.,1993;
Kissel et al., 2000). Ovaries for organ culture were obtained from
newborn mice (Jackson Laboratories). Ovaries from at least n=3
experimental and n=3 control animals were evaluated for each
timepoint in all analyses.
Tissue processing, immunohistochemistry and immunoﬂuorescence
Tissue sections from experimental and control samples were
placed on the same slide to ensure identical processing; at least n=3
slides were evaluated for each antibody. For immunohistochemistry,
tissues were ﬁxed in 10% formalin 1–12 h, then processed and
embedded in parafﬁn. 5 μm sections were deparafﬁnized in xylene,
and hydrated in an ethanol series. Slides were subjected to antigen
retrieval by boiling in 10 mM NaCitrate and cooled at RT×20 min.
Antibodies and titers for immunohistochemistry were: Foxo3 1:200
(Santa Cruz # sc-11351), p-Foxo3 (Thr32) 1:200 (Upstate # 07-695);
Ki67 1:50 (Lab Vision) Inhibin 1:200 (Lab Vision); p-Akt (Ser473)
1:50 (Cell Signaling # 9271) and t-Akt 1:1000 (Cell Signaling # 9272).
The detection system was Immpress (Vector, Burlingame, CA) or
Envision Plus (Dako, Carpinteria, CA). TUNEL was performed with the
Apoptag kit from Chemicon International (Temecula, California) per
the manufacturer's instructions.
Organ culture and histomorphometry, and follicle counts
Ovaries were photographed after explantation and at 4 and 8 days
and the relative ovarian volume was approximated by the equation
V=(long diameter×short diameter2). Average oocyte diameter was
determined on H&E tissue sections per the long diameter of oocytes
with nuclei in the plane of section (at least nN100 of such oocytes
were analyzed per ovary). Follicle counts were performed on H&E
stained tissue sections of entirely serially-sectioned ovaries. Only
follicles where the oocyte nucleus was in the plane of section were
counted. Every other section was used for counts of primordial and
primary follicles, every 6th section for secondary, antral and atretic
follicles and every 10th section for corpora lutea. A total of n=3 mice
for each genotype and age were counted (total of 6 ovaries). For
ovarian culture experiments, explanted ovaries were placed (37 °C, 5%
CO2) on Transwell Permeable supports (Costar, catalog # 3413) in
Waymouth's medium (Invitrogen catalog # 11220-035) supplemen-
ted with 10% fetal bovine serum, 0.23 mM Pyruvic acid, 3 mg/ml BSA,
1× ITS supplement (Invitrogen, catalog # 51300-044) and 1×
Antibiotic–Antimycotic (Invitrogen catalog # 15240-062). Kit inhi-
bition was performed by addition of 3 μM of Imatinib (Gleevec,
Novartis) to the media.
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KitlY719F females are born with a normal complement of primordial
follicles that undergo PFA
To understand the role of Kit signaling in PFA, a PI3K-dependent
process, females homozygous for the KitY719F “knock-in” allele were
generated through breeding of heterozygotes, which are phenoty-
pically normal (Kissel et al., 2000). Homozygous mice were born at
expected Mendelian ratios and were externally normal and in good
overall health. At postnatal day (PD) 3, KitY719F/KitY719F ovaries
were of normal size relative to wildtype ovaries (n=3) (Fig. 1A
and data not shown). Primordial follicle assembly is normally
completed by PD3; at this timepoint, primordial follicle numbers
and morphology were indistinguishable in wt vs. mutant ovaries,
indicating that germ cell function and oogenesis were normal up to
this stage (Figs. 1A–B, E).
By PD28 (prior to sexual maturity) wild-type ovaries contained
signiﬁcant numbers of growing follicles at various stages of matura-
tion, consistent with the fact that PFA begins at around PD3. Detailed
histologic analyses failed to reveal any defects in PFA at PD28 in
mutant ovaries, which contained large numbers of primary, second-Fig. 1. Analysis of KitY719F/KitY719F and sibling control (+/+) ovaries at postnatal day 3 reve
secondary follicles but no evidence of decreased PFA. A–D) H&E stained tissue sections, ba
genotype; error bars=s.e.m.). F) Relative follicle counts in serially-sectioned ovaries (n
2°=secondary.ary, and more advanced follicles (Figs. 1C, D). Follicle counts in
serially-sectioned ovaries did reveal some signiﬁcant abnormalities in
mutant ovaries, however. Primordial follicle numbers were slightly
decreased, although this was not statistically signiﬁcant (p=0.200,
Fig. 1F). However, there was a signiﬁcant increase (N2×) in the
number of morphologically normal primary follicles (p=0.001).
Abnormal primordial follicle maintenance and early follicle growth due
to deﬁcient PI3K signaling downstream of Kit
To identify more subtle or cumulative defects in follicle maturation
that might become evident only in older females, ovaries at 16 weeks
of age were analyzed. KitY719F/KitY719F ovaries contained some normal
follicles of all stages of maturation, but distinct abnormalities were
identiﬁed. There was an accumulation of abnormal follicles arrested at
an early stage of development, as previously reported (Kissel et al.,
2000). These abnormal follicles accumulated throughout the ovarian
stroma (Figs. 2A, B). Morphologically, these abnormal, apparently
growth-arrested follicles were morphologically intermediate between
primary (single layer of granulosa cells) and secondary follicles (two
layers of granulosa cells). The oocytes showed minimal enlargement,
but all of the associated granulosa cells had adopted a cuboidalals a normal endowment of primordial follicles and a lag in the transition of primary to
rs=100 µm. E) Relative oocyte counts in serially-sectioned ovaries (n=6 ovaries per
=6 ovaries per genotype; error bars=s.e.m.). Note: 0°=primordial, 1°=primary,
Fig. 2. Analysis of KitY719F/KitY719F and sibling control (+/+) ovaries at 16 weeks reveals defects in primordial follicle survival/maintenance and in early follicle maturation (primary
to secondary follicle transition). A–D) H&E stained tissue sections, bars=50 μm. B) Abundance of morphologically abnormal follicles arrested at the primary/secondary follicle stage
within the area enclosed by a dashed line. C–D) Higher magniﬁcation in boxed areas shown in A and B; insets show morphologically normal primordial follicles from elsewhere in
each section. E) Relative follicle counts in serially-sectioned ovaries (n=6 ovaries per genotype; error bars=s.e.m.). Due to the difﬁculty of reliably distinguishing primary from
secondary follicles (because of abnormal maturation phenotype), primary+secondary follicles were counted together. p values were calculated per the Student's t test.
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undergone PFA, but were arrested at the transition of the primary to
the secondary stage. Some of these follicles exhibited “pseudoantral”
spaces, suggesting that the granulosa cells continued to differentiate
to some extent despite their apparent growth arrest (antrum
formation normally takes place in much more advanced larger
follicles). The accumulation of these morphologically abnormal
follicles indicates that they persist as stable, long-lived structures
and do not undergo atresia despite their growth arrest. These ﬁndings
are consistent with prior studies, (e.g., Dong et al., 1996; Trombly et al.,
2009; Yang and Fortune, 2006, 2007), that argue for the existence of a
distinct primary to secondary follicle checkpoint. Despite the
decreased numbers of primordial follicles and the observed lag in
follicle maturation, KitY719F/KitY719F females were fertile at 16 weeks of
age. In single pair mating assays performed at 16 weeks, mutant
females had an average of 7.0 viable progeny vs. 6.8 for +/+ siblings
(n=5 females per genotype). This result further underscores the lack
of an overt PFA phenotype in KitY719F ovaries.
Follicle counts of serially-sectioned ovaries (n=3) showed a
signiﬁcant (approximately 3-fold) reduction in primordial follicle
numbers (p=0.001), and also an increase in abnormal primary/secondary follicles (p=0.002), as discussed above. The increased
numbers of primary/secondary follicles matched the decrease in
primordial follicles, such that the sum of primordial plus primary/
secondary follicles was similar in wt and mutant ovaries (Fig. 2E).
There were also signiﬁcant decreases in antral and atretic follicles,
consistent with the arrest phenotype and limited progression to these
more advanced stages in KitY719F/KitY719F ovaries. Somewhat unex-
pectedly given these results, mutant ovaries also harbored an
increased number of corpora lutea (p=0.004). The basis of this
abnormality has not been further explored, but raises the possibility
that Kit also regulates the growth or persistence of corpora lutea
(Brankin et al., 2004).
Growth arrest of primary/secondary follicles in KitY719F/KitY719F ovaries
is associated with abnormal retention and stabilization of Foxo3 protein
within oocyte nucleus
To gain further insights into the observed defects in follicle
maturation, the expression of several markers was analyzed. Granu-
losa cells in normal follicles are actively proliferating, as evidenced by
a high rate of positivity for the proliferation marker Ki67. In contrast,
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in the growth-arrested follicles had ceased proliferating (Fig. 3).
Consistent with their apparent long-term stability (Fig. 3), there was
no increase in apoptosis in either the granulosa cells or oocytes of the
growth-arrested follicles by TUNEL. Markers such as inhibin that are
induced following follicle activation and are detectable at the primary
follicle stage were unaltered in mutant follicles of comparable stage
(Fig. 3).
During normal ovarian development, Foxo3 protein is initially
cytoplasmic but becomes translocated into the nucleus during
primordial follicle assembly. The Foxo3 protein remains nuclear inFig. 3. Characterization of early follicle maturation defect in ovaries from adult (16 week
markers as indicated. For Ki67, positivity of scattered cells serves as internal positive control;
is expressed at similar levels in mutant and control follicles of comparable size and stage (
expression). Foxo3 localizes to the nucleus in primordial oocytes (inset) and shifts to the ooc
of lagging primary/secondary follicles in KitY719F/KitY719F ovaries.primordial follicles throughout life, where it serves to suppress their
growth. Following PFA, the Foxo3 protein shuttles from the nucleus to
the cytoplasm (Fig. 3), and then becomes degraded during the
secondary follicle stage (John et al., 2008). In KitY719F/KitY719F ovaries,
Foxo3 export and degradation did not occur; instead Foxo3 remained
distinctly nuclear. This suggests that Foxo3 exit from the nucleus is
required for the primary to secondary follicle transition. Strongly
supporting this idea, transgenic mice with enforced expression of
Foxo3 are subfertile and exhibit early follicularmaturation defects that
resemble those of KitY719F/KitY719F mice (Liu et al., 2007). Our
interpretation of these ﬁndings is that nuclear export of Foxo3 isKitY719F/KitY719F) and sibling (+/+) controls. Tissue sections were stained for various
for TUNEL stains, positive cells were present elsewhere in the slide (not shown). Inhibin
a more advanced secondary follicle on the right side of the +/+ panel shows higher
yte cytoplasm in primary follicles (+/+) but is abnormally retained within the nucleus
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plays an important function in regulating this PI3K-dependent
process. It is surprising, however, given previous studies, that Kit
signaling through PI3K is dispensable for PFA itself.
Reevaluation of the Steelpanda allele of Kit ligand (KitlSl-pan) reveals a
severe defect in the primary to secondary follicle transition with
abnormal nuclear Foxo3 retention, but not a deﬁciency of PFA per se
The unexpected ﬁnding that the KitY719F mutation did not prevent
PFA prompted a re-evaluation of the phenotype associated with the
Steelpanda allele of Kit ligand (KitlSl-pan) particularly as its phenotype has
been interpreted by some investigators as evidence supporting a role
for Kit in PFA. As previously described, KitlSl-pan/KitlSl-pan ovaries at
3 weeks of age were much smaller than sibling controls (Bedell et al.,
1995; Huang et al., 1993), reﬂecting a signiﬁcantly diminished initial
endowment of primordial follicles (Fig. 4A). Histologic examination of
these ovaries revealed a sparsity of primordial follicles, as previously
reported. However, morphologic analysis of the remaining follicles
revealed a growth arrest not at the primordial to primary follicle
transition (which would represent evidence for a defect in PFA) but
rather at the primary to secondary follicle transition, akin to what was
observed in KitY719F/KitY719F mice. The vast majority of the follicles in
KitlSl-pan/KitlSl-pan ovaries were associated with a distinct layer of
cuboidal granulosa cells that were increased in number relative to a
normal (unactivated) primordial follicle (Fig. 4B, see also inset).
Follicle counts of serially-sectioned ovaries (n=3) conﬁrmed that the
great majority of follicles in KitlSl-pan/KitlSl-pan ovaries were arrested at
the primary, not the primordial stage (Fig. 4C). Only rare secondary
follicles were observed, and none beyond the secondary follicle stage.
These results are consistent with our analysis of KitY719F/KitY719F mice
in that bothmutations resulted in an arrest at the primary to secondary
follicle stage, pointing to a speciﬁc role of Kit–PI3K signaling in
promoting the primary to secondary follicle transition. Immunoloca-
lization of the Foxo3 protein in KitlSl-pan/KitlSl-pan ovaries again showed
retention and stabilization of nuclear Foxo3, further supporting theFig. 4. Evaluation of KitlSl-pan/KitlSl-pan ovaries reveals defect in primary to secondary follicle tr
ovaries are highly atrophic due to pleiotropic defects in primordial follicle numbers and fol
Most follicles in KitlSl-pan/KitlSl-pan ovaries are arrested at the primary, not the primordial fo
associated with each follicle (inset: normal primordial follicle from control ovary). C) Re
bars=s.e.m.). D) Foxo3 immunohistochemistry reveals nuclear retention of Foxo3 in KitlSlnotion that Kit regulates the primary to secondary follicle transition
through the nuclear retention/stabilization of Foxo3. Thus, although
the pleiotropic and severe nature of the KitlSl-pan/KitlSl-pan phenotype
does obscure its interpretation, rigorousmorphologic analysis does not
provide compelling evidence for a defect in PFA itself but rather further
supports roles in primordial follicle survival/maintenance and in the
primary to secondary follicle transition.
In vitro pharmacologic inhibition of Kit results in decreased PFA
To further explore the roles of Kit in the regulation of PFA and to
attempt to reconcile these in vivo observations with prior in vitro
studies, we performed studies with the Kit small-molecule inhibitor
imatinib mesylate (trade name, Gleevec). Treatment of ovaries
explanted from newborn wild-type pups resulted in a small but
statistically signiﬁcant decrease in ovarian size after 8 days in culture
(Figs. 5A, B). Furthermore, this decrease in ovarian size correlated
with a decreased average oocyte diameter (Figs. 5C, D). Western
analysis showed decreased Foxo3 phosphorylation (Fig. 5E). One
signiﬁcant technical limitation is that in situ (immunohistochemical)
andWestern approaches proved of insufﬁcient sensitivity to detect Kit
autophosphorylation and thus document Kit inhibition, whereas we
were readily able to document Kit inhibition in Mo7e cells (data not
shown). With the additional caveat that this high dose may inhibit a
variety of other related RTKs or possibly unrelated kinases, and may
also produce other non-speciﬁc toxic effects at the level of the oocyte
or other ovarian compartments, these results are consistent with
previous in vivo studies (discussed below).
Discussion
This study demonstrates that inactivation of Kit signaling via the
PI3K pathway results in decreased primordial follicle survival and the
abnormal accumulation of ovarian follicles arrested at an early stage
of maturation. Surprisingly, however, the KitY719F mutation previously
shown to disrupt binding of Kit to PI3K (and hence Kit-inducedansition associatedwith abnormal Foxo3 nuclear retention and stabilization. A) KitlSl-pan
licle maturation. B) H&E of tissue section showing predominant follicular morphology.
llicle stage, as evidenced by the cuboidal morphology and numbers of granulosa cells
lative follicle counts in serially-sectioned ovaries (n=6 ovaries per genotype; error
-pan ovaries. Bars for B and D=50 µm.
Fig. 5. Effects of imatinib treatment on ovary and follicle size in vitro. Ovaries were explanted on the day of birth and placed in culture media+/−3 μM imatinib. A) Representative
photographs of ovaries after 8 days of culture. B) H&E stained sections of treated and untreated ovaries. Imatinib treatment results in decreased average oocyte size. C) Ovarian
volume in untreated vs. treated ovaries. Imatinib treatment results in decreased average ovarian volume, (n=3 ovaries; error bars=s.e.m.). D) Average oocyte diameters (n=3
ovaries; error bars=s.e.m.). Asterisk indicates p valueb0.05 per Student's t test. For C and D, grey bars=imatinib-treated; white bars=untreated controls. E) Western analyses of
imatinib-treated and untreated controls. t=total protein; p=phosphorylated protein.
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not result in a signiﬁcant failure of PFA, as would be expected if Kit
were the primary upstream receptor controlling this biological
process. To the contrary, KitY719F/KitY719F female mice appear to
undergo PFA normally, and adult females contain large numbers of
growing follicles. Consistent with these results, we also found that a
Kitl mutation that results in decreased ovarian levels of Kitl (Bedell
et al., 1995; Huang et al., 1993) similarly affects primordial follicle
survival and the primary to secondary follicle transition, but not PFA
per se. These ﬁndings suggest that other upstream receptors may
serve this function. Previous studies showing that increased PI3K
signaling triggered by an oocyte-speciﬁc Pten gene knockout promotes
global PFA (John et al., 2008; Reddy et al., 2008) argues against the
alternative hypothesis that Kit is the overriding upstream receptor
regulating PFA but that it acts through other (i.e. non-PI3K) signaling
pathways.
There are two possible interpretations of the accelerated depletion
of primordial follicles observed in the KitY719F mutant. First, the
observed depletion may be due to decreased survival of primordial
oocytes. This is an attractive hypothesis because Kit and Kitl are well-
established survival factors for germ cells at various stages of
development, particularly primordial germ cells (Bedell and Mahakali
Zama, 2004). TUNEL analyses at 12 weeks and earlier timepoints
failed to identify increased apoptosis in primordial oocytes of KitY719F
mutant mice (data not shown). However, an increase in oocyte
apoptosis in KitY719F ovaries would be cumulative and very gradual (at
16 weeks one-third of primordial follicles still remain). Thus the
increased rate of apoptosis would likely be below limits of detection,
particularly as the rate of primordial oocyte apoptosis in normal adult
ovaries is low (Tilly, 2001). It is also formally possible that the
observed depletion is due to increased PFA (i.e. that Kit signaling,
counter to expectations, normally suppresses PFA), because the
decrease in primordial follicle numbers roughly approximates the
observed increase in primary+secondary follicles (Fig. 2E). However,this is more likely a coincidence due to the block in the transition of
primary to secondary follicles. Consistent with this idea, imatinib
treatment of cultured ovaries was not associated with an increased
oocyte diameter (Fig. 5). Thus, we favor the idea that Kit serves an
important physiologic function as a pro-survival factor for primordial
oocytes.
We also observed that the Foxo3 protein is abnormally stabilized
within the oocyte nucleus in both the KitY719F and KitlSl-pan mutants,
arguing that Kit signaling through PI3K is important for regulating the
primary to secondary follicle transition, and furthermore, that Foxo3 is
a negative regulator of the primary to secondary follicle transition in
addition to PFA. This suggests that Foxo3 degradation promotes the
primary to secondary follicle transition, a ﬁnding that is entirely
consistent with an earlier study showing that enforced Foxo3
expression in oocytes results in an arrest at the primary follicle
stage (Liu et al., 2007). Thus, while PFA appears to be Kit-independent,
the primary to secondary follicle transition clearly is not.
The results of the imatinib studies were consistent with previous
in vitro studies showing a growth inhibitionwith various Kit inhibitory
treatments (Driancourt et al., 2000; Huang et al., 1993; Packer et al.,
1994; Parrott and Skinner, 1999; Thomas et al., 2008; Thomas and
Vanderhyden, 2006; Yoshida et al., 1997). The results could be
reconciled with the in vivo genetic analyses by hypothesizing that
Kit is essential for PFA but that it signals through multiple down-
stream pathways, such that the PI3K pathway is nonessential. This
however appears to be at odds with the Pten knockout studies
discussed above. Despite the high concentrations of imatinib
employed, it is possible that effective concentrations were not
achieved within oocytes. For example, Mdr1, the ATP-dependent
transporter that exports small-molecule drugs from chemoresistant
tumor cells, is normally expressed at very high levels within oocytes
and functions to limit the accumulation of various drugs within
oocytes (Elbling et al., 1993; Gallardo et al., 2007). It would thus be
highly desirable for these studies to be able to document effective
299G.B. John et al. / Developmental Biology 331 (2009) 292–299inhibition of Kit within the oocyte. In principle, this could be
performed through in situ immunodetection of phosphorylated Kit
protein, but currently available phospho-speciﬁc antibodies were not
sufﬁciently speciﬁc and/or sensitive (data not shown).We also cannot
exclude the possibility that the relatively high concentrations of
imatinib inhibited other kinases, and thus, that the observed results
are non-speciﬁc.
In summary, our analyses of two distinct mutants provide evidence
that Kit functions via PI3K to promote the survival of primordial
oocytes and the transition of primary to secondary follicles. Although
in vitro studies provide some support for a role of Kit in promoting PFA,
in vivo genetic analyses argue that Kit is nonessential in engaging the
PI3K pathway to regulate PFA. The identiﬁcation of upstream
components and presumptive extracellullar signals regulating PFA
remains an outstanding challenge in ovarian biology that will beneﬁt
from reﬁnements in genetic and other experimental approaches.
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